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Chapter 1     Identification of interacting factors with ERCC1-XPF 
 
1-1. Introduction 
DNA damage response 
Our genomic DNA is constantly exposed to various kinds of DNA damaging 
factors, which can be exogenous and endogenous, such as ultraviolet (UV) light, 
ionizing radiation, reactive oxygen species, and replication stresses (Friedberg et al., 
2006).  If such DNA damage are not properly processed, they will cause mutations, 
cellular senescence, death, and oncogenesis.  To prevent from developing those 
harmful consequences and maintain DNA sequence integrity, our cells have multiple 
DNA damage response pathways; mismatch repair (MMR), nucleotide excision 
repair (NER), base excision repair (BER), interstrand crosslink repair (ICL), 
homologous recombination (HR), non-homologous end-joining (NHEJ) and so on 
(Bouwman et al., 2012).  Analysis of the detailed mechanisms of DNA damage 
response would provide us with promising ways for prevention and treatment of 




UV-induced photolesions and nucleotide excision repair 
Nucleotide excision repair (NER) is a major mechanism for repairing dimeric 
pyrimidine photolesions by ultraviolet light or bulky chemical base adducts.  The 
major UV photoproducts are the cyclobutane pyrimidine dimers (CPD) and (6-4) 
photoproducts (6-4PP) (Friedberg et al., 2006; Schärer, 2013).  The biochemical 
mechanism of NER has been well characterized, which includes damage recognition, 
dual incisions, release of excised oligonucleotides, repair synthesis to fill the gap and 
ligation (Hu et al., 2017; Adebali et al., 2017a; Adebali et al., 2017b; Li et al., 2018) 
(Fig. 2). 
     Deficiency in the NER is related to a rare hereditary disease, xeroderma 
pigmentosum (XP), which is classified into seven XP complementation groups, A (XP-
A) through G (XP-G) (Friedberg et al., 2006; Cleaver et al., 2009).  All seven 
responsible genes were already identified and are known to code proteins essential 
or sub-essential for NER reaction.  XP patients are characterized by 
photosensitivity, pigment changes and a predisposition to skin cancer on areas 
exposed to sun light, which are potentially caused by their inability to repair UV-




ERCC1-XPF heterodimer essential for NER 
ERCC1-XPF is one of the indispensable NER factors, which is involved in not only 
NER, but also other DNA repair systems, including ICL repair (De Silva et al., 2000; 
Kuraoka et al., 2000; De Silva et al, 2002; Niedernhofer et al., 2004; Fisher et al., 
2008; Klein et al., 2014), HR (Sargent et al., 1997; Adair et al., 2000; Ahmad et al., 
2008; Al-Minawi et al., 2008; Bennardo et al., 2008).  The ERCC1-XPF complex is a 
structure specific endonuclease, which makes a nick at the junction of double-
stranded to single-stranded DNA transition with a polarity of 5’ to 3’ direction 
(Matsunaga et al., 1996; Sijbers et al., 1996; de Laat et al., 1998a).  As a result, DNA 
substrates for this endonuclease contain a special structure such as a splayed arm, 
stem loop, bubble, or 3’ flap (Fig. 2B).  ERCC1 and XPF interact with each other via 
their C-terminal helix-hairpin-helix (HhH) regions (de Laat et al., 1998b) (Fig. 2A).  
XPF protein contains a catalytic domain, although the structural support of ERCC1 
is required for its endonuclease activity (Fig. 1A and B) (Enzlin and Scharer 2002; 
Tripsianes et al., 2005).   
  
Pathology associated with ERCC1-XPF malfunction  
In humans, germline mutations in both alleles of XPF/ERCC4 gene causes not only 
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XP complementation group F (shortly XP-F), but also other severer genetic disorders, 
XFE progeroid syndrome, Fanconi anemia (FA), Cockayne syndrome (CS) and a 
combined form of XP/CS (Gregg et al., 2011; Manandhar et al., 2015).  In contrast, 
no ERCC1 mutations have been identified in XP patients so far.  It was recently 
reported that one of the patients suffered from cerebro-oculo-facio-skeletal (COFS) 
syndrome harbors mutations in ERCC1 gene (Kashiyama et al., 2013).  This patient 
manifested severe developmental failure, microcephaly and skeletal abnormalities.  
In mouse models, two ERCC1 knockout strains were independently generated by 
two groups (McWhir et al., 1993; Weeda et al., 1997), and showed severe growth 
failure and nuclear abnormality and died at approximately 3 weeks before weaning.  
The mice lacking ERCC1 also developed various symptoms including progressive 
neurodegeneration, rapid turnover of hematopoietic cells, musculo-skeletal and 
nervous system defects, and impaired liver function (Núñez et al., 2000; 
Niedernhofer et al., 2006).  Taken together, it is clear that the normal function of 
ERCC1-XPF is important for not only cancer prevention but also normal 




Cellular levels of ERCC1-XPF 
The heterodimer formation of ERCC1 and XPF is also known to be also necessary 
for their stability (Biggerstaff et al., 1993; Reardon et al., 1993; van Vuuren et al., 
1993).  XP-F patients carry a missense mutation in at least one allele of 
XPF/ERCC4 genes (Gregg et al., 2011; Manandhar et al., 2015) and show only 
marginal or undetectable level of XPF protein, whereas ERCC1 protein level is also 
markedly reduced in various XP-F cell strains (Yagi et al., 1997).  Similarly, ERCC1-
mutated cells showed low XPF level (Jaspers et al., 2007) and ERCC1 knockdown 
caused the significant reduction of XPF protein level without affecting mRNA level 
(Arora et al., 2010).  It has been also shown that ERCC1 can fold only in the 
presence of XPF in vitro, suggesting that XPF acts as a scaffold for the proper folding 
of ERCC1 (Tripsianes et al., 2005; Choi et al., 2005).  In addition, the cellular level 
of ERCC1-XPF is well known to influence the efficacy of platinum-based cancer 
chemotherapy.  However, the detailed mechanism of how the cellular levels of 




Objective of this study 
 In this study, I set a goal to identify novel interacting factors with ERCC1-XPF and 
uncover their functions to obtain the information regarding regulatory mechanisms 
of ERCC1-XPF.  At Chapter 1, I have tried to identify novel interacting factors with 
ERCC1-XPF using Flp-In T-REx 293 cells conditionally expressing FLAG- and 
6xHis-tagged ERCC1 or XPF and tandem purification followed by mass spectrometry.  
I obtained 699 candidates from the fractions and found 14 kinds of E3 ligases and 5 
kinds of deubiquitinases included.  After immunoprecipitation experiments and 
subsequent siRNA-mediated knockdown experiments, I found that DCAF7 and 
USP11 are novel interacting proteins with ERCC1-XPF and their knockdown affects 
cellular protein levels of ERCC1-XPF.  At Chapter 2, I have focused on the 
functional analysis of DCAF7 and ERCC1-XPF interaction and found that DCAF7 is 





Overexpression of double-tagged ERCC1 or XPF and their tandem affinity 
purification. 
To explore a novel interacting protein(s) of ERCC1-XPF, I employed affinity 
purification and mass spectrometry using Flp-In T-REx 293 cells conditionally 
expressing FLAG- and 6xHis-tagged ERCC1 or XPF upon the treatment of 
tetracycline or its derivatives.  The cell lines were established by Dr. Joyce T. 
Reardon, and were kindly provided by Dr. Aziz Sancar, University of North Carolina 
at Chapel Hill, USA. The two cell lines and their parental cells (negative control) 
were treated with tetracycline for 48 h and each proteins were visualized by 
immunoblotting (Fig. 3A).  I could detect overexpressed double-tagged ERCC1 or 
XPF, which are much higher levels compared to the endogenous ERCC1 or XPF.  
Furthermore, the endogenous ERCC1 was downregulated and almost depleted due 
to the overexpression of FLAG-ERCC1-6xHis.  Next, I optimized tandem 
purification of those bait proteins by first Ni-NTA agarose and subsequent anti-
FLAG antibody resin, and found the condition under which FLAG-ERCC1-6xHis can 
be efficiently isolated (Fig. 3B).  I validated the interaction between overexpressed 
FLAG-ERCC1-6xHis and endogenous XPF or ectopic FLAG-XPF-6xHis and 
endogenous ERCC1 using co-immunoprecipitation experiments (Fig. 3C).  Finally, 
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I visualized all proteins in each sample by silver staining to check how abundant 
non-specific proteins are included (Fig. 3D).  After the first Ni-NTA purification, 
there are still many bands detected in the sample from parental cells, indicating that 
the fractions contains non-specific proteins (Lane 2).  After the subsequent anti-
FLAG antibody resin purification, however, most of non-specific bands were 
eliminated and only a few bands were visible (Lane 3).  Additionally, a strong signal 
was observed at the estimated molecular size 103 kDa in FLAG-ERCC1-6xHis 
fraction (Lane 7) or at the estimated band size 36 kDa in FLAG-XPF-6xHis fraction, 
suggesting the detection of endogenous XPF or ERCC1 co-purified, respectively.  
More importantly, in both tandem-purified fractions, there were many other bands 
which were not seen in the fraction of parental cells (Lane 3 vs 7).  I concluded that 
the fractions after the tandem purification would be applicable to mass spectrometry 
analysis. 
 
List of ERCC1- or XPF-interacting factors identified by mass spectrometry analysis 
I submitted the purified fractions to the UNC Michael Hooker Proteomics 
Center, University of North Carolina at Chapel Hill (USA) for mass spectrometry.  
In total, polypeptides from 699 proteins were detected, which include several 
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proteins previously reported to interact with ERCC1-XPF, XPA, MSH2 and SLX4 
(Park and Sancar, 1994; Lan et al., 2004; Muñoz et al., 2009), indicating that the 
purification and mass spectrometry were properly conducted for our purposes.  On 
the other hand, RPA (a known XPF interactor) and USP45 (a known ERCC1 
interactor) (de Laat et al., 1998; Perez-Oliva et al., 2015) were not detected.  The 
lists include many proteins related to the ubiquitination/deubiquitination system, 
DNA replication, molecular chaperons, heat shock proteins, ribosomal proteins and 
so on (data not shown).  In particular, I was interested in the proteins related to the 
ubiquitination/deubiquitination system, since they are possibly implicated in the 
regulation of ERCC1-XPF stability.  In this category, 14 kinds of E3 ubiquitin 
ligases and 5 kinds of deubiquitinases were included (Table 1). 
 
Validation of each interaction by transient co-expression and co-
immunoprecipitation. 
    Mass spectrometry is very powerful and sensitive, but often includes false-
positive proteins.  I next carried out co-immunoprecipitation experiments by 
overexpressing epitope-tagged candidate interactors along with tagged or non-
tagged ERCC1 in HEK293T cells to ascertain their associations as a second 
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screening.  Among the listed proteins related to the ubiquitination/deubiquitination 
system, I could obtain or make expression constructs of 3xMyc-STUB1, 3xMyc-
KCTD13, DCAF7-Myc, GFP-RNF220, 3xMyc-FBXO22, USP11-Myc, USP30-Myc, 
USP46-Myc, V5-TRIM28, 3xMyc-RNF40, 3xMyc-RNF2, MID1-Myc, GFP-CBL, 
FLAG-TRIM25, and FLAG-USP7.  Those proteins were co-overexpressed with 
3xFLAG-ERCC1 or non-tagged ERCC1 and co-immuprecipitated by various epitope-
tag antibodies.  As a result, 3xMyc-STUB1, 3xMyc-KCTD13, DCAF7-Myc, GFP-
RNF220, 3xMyc-FBXO22, USP11-Myc, USP30-Myc and USP46-Myc were co-
precipitated with ERCC1, while V5-TRIM28, 3xMyc-RNF40, 3xMyc-RNF2, MID1-
Myc, GFP-CBL, FLAG-TRIM25 and FLAG-USP7 were not (Fig. 4).  
 
Depletion of DCAF7 or USP11 affects the cellular levels of ERCC1-XPF. 
     Among the eight proteins that were verified to interact with ERCC1-XPF by 
immunoprecipitation experiments, I tested the impacts of siRNA-mediated 
knockdown of six interactors, DCAF7, STUB1, KCTD13, USP11, USP30 and USP46, 
on ERCC1-XPF protein level.  As a result, I found that the knockdown of DCAF7 or 
USP11 in U2OS cells affects cellular level of ERCC1-XPF (Fig. 6), while the 
knockdown of other four interactors did not.  In case of DCAF7 knockdown, the 
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cellular levels of both ERCC1 and XPF were markedly diminished. On the other 
hand, USP11 knockdown moderately reduced only ERCC1 level.  These results 








In DNA maintenance systems, ERCC1-XPF is one of the most important factors 
which functions in not only NER but also other several DNA damage responses.  
ERCC1 and XPF need to form heterodimer to stabilize each other (Yagi et al., 1997; 
Jaspers et al., 2007; Tripsianes et al., 2005; Choi et al., 2005; Sanjeevani et al., 2010). 
ERCC1 was reported to interact with USP45 deubiquitinase, which appears to 
facilitate ERCC1 recruitment to DNA lesions rather than ERCC1 stability (Perez-
Oliva et al., 2014).  No other proteins involved in ubiquitination-mediated 
regulation of ERCC1-XPF were currently known. 
For further understanding the function and regulation of ERCC1-XPF complex, 
I thought it is essential to identify novel interacting factors.  In this study, I 
conducted tandem purification of double-tagged ERCC1 or XPF and mass 
spectrometry analysis, leading me to identify 699 candidate proteins.  In particular, 
I have focused on 14 kinds of E3 ligases and five kinds of deubiquitinases included 
in the candidates.  Verification process by co-immunoprecipitation experiments 
indicated that STUB1, KCTD13, DCAF7, RNF220, FBXO22, USP11, USP30 and 
USP46 appear truly positive as ERCC1-XPF interactors tested so far (Fig, 4).  
STUB1 is known to interact with heat shock proteins, HSP70 and HSP90, and 
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ubiquitinate misfolded protein for their proteolytic degradation (Ballinger at al., 
1999; Connel et al., 2001).  STUB1 also ubiquitinates DNA Pol  involved in base 
excision repair (BER) and induces its degradation to regulate BER activity (Parsons 
et al., 2008).  So STUB1 might also be involved in NER activity regulation by 
ubiquitinating ERCC1-XPF.  KCDT13 is induced by TNF- and interacts with 
PCNA and DNA Pol  to activate DNA Pol  (He et al., 2001).  DCAF7, also known 
as WDR68 or HAN11, controls the cellular signaling as a scaffold protein or an 
adaptor protein and also functions as a substrate receptor of Cul4-DDB1 E3 ligase 
complex (see the Introduction section of Chapter 2).  USP11 was reported to be 
deubiquitinase and stabilize p53 promoting DNA damage responses (Ke et al., 2014).   
Knockdown experiments by siRNAs in selected six interactors revealed that 
DCAF7 and USP11 affect the steady state level of ERCC1-XPF (Fig. 6).  Specially, 
the impact of DCAF7 was more prominent and ERCC1-XPF level was reduced to 
~20%.  I decided to focus on DCAF7 and at Chapter 2, the functional analysis of the 




Chapter 2 Functional analysis of one of the interacting proteins, DCAF7 
 
2-1.   Introduction 
Background of DCAF7, a novel interacting protein with ERCC1-XPF 
DDB1- and CUL4-associated factor 7 (DCAF7, also known as WDR68 or 
HAN11) is a WD40 domain which was discovered by a research of a kinase DYRK1A 
(dual-specificity tyrosine-phosphorylation regulated protein kinase/dual-specificity 
YAK1-related protein kinase) (Skurat and Dietrich, 2004).  DCAF7 has five WD40 
repeats.  The N- and C-terminal have no manifest sequence similarity with the 
WD40 repeats. Because most of the structurally specified WD40 proteins contain 
seven WD40 repeats and form seven-bladed-propeller structures (Stirnimann et al., 
2010), it is speculated that DCAF7 has as least five -propeller blades (Fig. 5A).  
Miyata et al., constructed a structural model of mammalian DCAF7 by analyzing its 
amino acid sequence (Miyata et al., 2014).  DCAF7 is ecclesial for the proliferation 
and survival of mammalian cells (Ritterhoff et al., 2010; Miyata et al., 2011).  
DCAF7 can function as a substrate receptor of Cullin4-DDB1 complex and 
ubiquitinates target proteins, such as DNA ligase I and regulate their cellular levels 
(Peng et al., 2016).  Since DCAF7 doesn’t have nuclear localization signal, DCAF7 
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need to interact with DYRK1A which is a family of mammalian protein kinases 
(Miyata et al., 2011).  DCAF7 is required for normal cellular levels of DYRK1A and 
DYRK1B (Yousefelahiyeh et al., 2018).  DCAF7 works as a scaffold and mediates 
the interaction between kinases, DYRK1A, HIPK2 and MEKK (Glenewinkel et al., 
2016; Ritterhoff et al., 2010).  DCAF7 and DYRK1A form a complex and 
phosphorylates the C-terminal region of RNA polymesase II and promote myogenesis 
(Yu et al., 2019). 
 
Molecular chaperon TRiC 
     In cells, newly synthesized proteins need to be properly folded. Molecular 
chaperones assist folding of many proteins.  The chaperonin-containing T-complex 
(TRiC) is an ATP-dependent type II (group II) chaperon, prevents misfolding and 
aggregation during folding of many proteins (Hartle et al., 2002; Spiess et al., 2004; 
Horwich et al., 2007).  TRiC consists of eight subunits (TCP1 to TCP1) (Fig. 5B) 
(Dunn et al., 2001).  TRiC mainly recognizes exposed hydrophobic residues 
(Horwich et al., 2007), but charged animo acid residues can also be recognized (Spiess 
et al., 2006).  It is reported that TRiC binds to DCAF7 and promotes its folding and 




Functional analysis of DCAF7 
     Here at Chapter 2, I conducted several functional analysis to determine the 
mechanisms of DCAF7 against ERCC1-XPF.  By co-immunoprecipitation analysis, 
I found out that DCAF7 interacts with XPF, not ERCC1. I further tried to 
determine the interacting region by partial XPF expression vectors.  I speculate 
that DCAF7 interacts with XPF via not only one site but also multiple sites.  The 
stabilization of ERCC1-XPF by DCAF7 was not depend on Cullin4-DDB1 complex.  
The reduction of ERCC1-XPF by depleted DCAF7 was not fully dependent on 26S 
proteasome, but some newly synthesized ERCC1 was partly dependent.  
Furthermore, I identified the molecular chaperon, TRiC as another regulator of the 
cellular levels of ERCC1-XPF. Importantly, DCAF7-depleted cells showed less 
efficient removal of UV-induced (6-4) photoproducts from the genome, indicating 




2-2.   Results 
DCAF7 binds to ERCC1-XPF heterodimer through the association with XPF 
I first tried to confirm the interaction between DCAF7 and ERCC1 or XPF by 
co-immunoprecipitation experiments with HEK293T cells transiently expressing 
epitope-tagged DCAF7 and ERCC1 (Figs. 7A) or XPF (Figs. 7B and C).  In all types 
of combination, I could detect the co-immunoprecipitation between DCAF7 and 
ERCC1 or XPF, suggesting that DCAF7 indeed associates with ERCC1-XPF 
heterodimer in cells. 
I next asked which subunit of the heterodimer interacts with DCAF7.  For this 
purpose, instead of HEK293T cells, I used XP2YO(SV) cells from XP-F patient, in 
which mutant XPF protein is undetectable and the protein level of ERCC1 is 
marginal due to its destabilization (Matsumura et al., 1998).  Interestingly, similar 
immunoprecipitation experiments exhibited co-precipitated DCAF7 and XPF (Figs. 
8A and B), but not DCAF7 and ERCC1 (Figs. 8C and D).  However, co-transfection 
of an increasing amount of XPF plasmid enabled us to detect ERCC1 coprecipitated 
with FLAG-DCAF7 by anti-FLAG antibody resin (Fig. 8E).  These results strongly 




XPF interacts with DCAF7 via multiple sites.  
XPF consists of Helicase-like domain, nuclease domain and Helix-hairpin-helix 
motif, class 2.  To identify which part of XPF is responsible for the DCAF7 binding, 
I made deletion mutants of Myc-tagged XPF (Fig. 9A) and examined their ability to 
interact with FLAG-tagged DCAF7 by co-immunoprecipitation analysis in 
XP2YO(SV) cells.  Unexpectedly, both XPF (1-515)-Myc and XPF (516-916)-Myc 
which are not partially overlapped were co-immunoprecipitated with FLAG-DCAF7 
(Fig. 9B and 9C).  I assumed that the central part of XPF associates with DCAF7. 
Shorter region of C-terminus, XPF (719-916)-Myc was also co-immunoprecipitated 
in XP2YO(SV) (data not shown).  Shorter region of N-terminus XPF (1-457)-Myc 
couldn’t be overexpressed in XP2YO(SV) cells, but could be in HEK293T cells and 
also co-immunoprecipitated with FLAG-DCAF7 (data not shown).  For these results, 
it is speculated that DCAF7 interact with XPF via multiple sites.  DCAF7 might 
interact with their target proteins via several regions. I couldn’t achieve any valuable 
functional insights from partial XPF and DCAF7 interaction analysis. 
 
Depletion of DCAF7 reduces the cellular level of ERCC1-XPF.  
To examine a functional role of DCAF7 and ERCC1-XPF interaction, U2OS 
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cells were transfected with DCAF7 siRNA (#1) and monitored for the cellular levels 
of XPF and ERCC1, in addition to DCAF7.  Under the condition that DCAF7 was 
gradually decreased in a time-dependent manner, the protein levels of XPF and 
ERCC1 were also downregulated with similar kinetics (Fig. 10A).  The DCAF7 
depletion-induced ERCC1-XPF downregulation was reproducible (Fig. 10C), 
whereas the cellular levels of other NER factors (DDB1, DDB2 and XPB) were not 
affected by DCAF7 depletion (Fig. 10B).  Moreover, I had a similar observation 
using HeLa cells with two different DCAF7 siRNAs, #1 and #2, targeting distinct 
regions of DCAF7 mRNA (Fig. 11A), indicating that this phenomenon is neither cell 
line-specific nor due to off-target effects. 
The molecular chaperon TRiC, which plays an important role in proper folding 
of many proteins (Spiess et al., 2004; Horwich et al., 2007), has been reported to 
interact with DCAF7 and promote its folding and nuclear localization (Miyata et al., 
2014).  I examined the impact of depletion of TCP1, one of eight subunits of TRiC, 
on the protein level of ERCC1-XPF.  As shown in Fig. 10D, transfection of specific 
siRNA (#1) caused efficient TCP1knockdown, but no change in DCAF7 protein 
level as reported previously (Miyata et al., 2014).  The cellular level of ERCC1-XPF 
was also downregulated as expected, although no striking impacts on DDB2 and XPA 
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levels.   Again, this phenomenon was reproducible (Fig. 10E) and was observed 
with another TCP1siRNA sequence (#2) as well (Fig. 11B).  Taken together, these 
results suggest that DCAF7 is required for maintaining the normal cellular levels of 
ERCC1-XPF. 
 
DCAF7-mediated regulation of ERCC1-XPF level is independent of Cul4-DDB1 E3 
ligase and 26S proteasome. 
DCAF7 is known to form a complex with Cul4-DDB1 and to function as a 
substrate receptor that determines the substrate specificity of the E3 ligase complex.  
I wished to know whether the depletion of DDB1 also causes the downregulation of 
ERCC1-XPF.  However, transfection of DDB1 siRNA affected neither the basal 
levels of ERCC1-XPF (Fig. 12A) nor the downregulation of ERCC1-XPF upon DCAF7 
depletion (Fig. 12B), indicating that DDB1 and probably also Cul4 are unlikely to 
participate in this mechanism.   
I further asked whether the downregulation of ERCC1-XPF by DCAF7 
depletion is dependent on 26S proteasome.  After transfection with DCAF7 siRNA, 
a proteasome inhibitor MG-132 was added to cell culture at 12 h and treated for 12 
h before cell lysis.  Immunoblot analysis showed that MG132 partially suppresses 
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the downregulation of ERCC1, while XPF level is unchanged (Fig. 12C).  Non-
ATPase regulatory subunit 14 (PSMD14), one of proteasome subunits, possesses a 
deubiquitinase activity and is essential for the proteolytic function of proteasome 
(Verma et al., 2002).  Partial knockdown of PSMD14 by siRNA elevated basal levels 
of p53 and also DCAF7, XPF and ERCC1.  Importantly, cotreatment of DCAF7 
siRNA again caused the downregulation of ERCC1 and XPF (but not p53) (Fig. 12D), 
suggesting that the accumulation of ERCC1 and XPF by PSMD14 knockdown and 
their downregulation by DCAF7 knockdown are mutually independent. 
Taken together, I suggest that the ubiquitin-proteasome system is not mainly 
implicated in DCAF7-mediated regulation of ERCC1-XPF level, although some 
fraction of ERCC1 regulation might be proteasome-dependent. 
 
Depletion of DCAF7 causes the suppression of NER activity. 
ERCC1-XPF is an indispensable factor for the dual incision reaction of NER.  
Given that DCAF7 depletion reduces the protein level of ERCC1-XPF, I wished to 
know the impact of DCAF7 depletion on cellular NER activity.  To this end, I 
transfected HeLa cells with DCAF7 siRNA (#1) and measured the repair kinetics of 
6-4PP induced by UV-C irradiation.  DCAF7-depleted cells showed a significantly 
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slower rate of 6-4PP removal, compared to the undepleted control cells (Fig. 13A).  I 
also performed the same experiment with Flp-In T-REx 293/FLAG-XPF-3xHis cells 
to check whether inducible expression of XPF can rescue the delay of 6-4PP repair.  
As seen in Fig. 13B, DCAF7 knockdown again suppressed 6-4PP repair, although 
less significantly compared with DCAF7-depleted HeLa cells, probably due to low 
knockdown efficiency in this cell line.  Importantly, the treatment of doxycycline 
elevated the cellular level of exogenous FLAG-XPF-6xHis and even endogenous 
ERCC1, and restored the full 6-4PP repair ability.  Taken together, these results 
suggest that DCAF7 plays an important role in maintaining normal NER activity by 
stabilizing ERCC1-XPF endonuclease.  
 
DYRK1A kinase activity inhibitor, Harmine doesn’t affect the cellular levels of 
ERCC1-XPF 
There are several reports that DCAF7 acts as a scaffold of kinases and it is 
necessary for kinase pathways.  Kinase DYRK1A interacts with DCAF7 and it is 
essential for the nuclear localization of DCAF7 (Miyata et al., 2011).  DCAF7 is also 
required for normal cellular levels of DYRK1A and DYRK1B (Mina et al., 2018).  
The complex of DYRK1A and DCAF7 phosphorylates the C-terminal region of RNA 
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polymerase II and promote myogenesis (Dan et al., 2019).  DCAF7 needs to serve a 
scaffold for kinases, HIPK2 and MEKK1 and their phosphorylation pathways 
(Stefanie et al., 2010).  I speculate that DCAF7 acts as a scaffold protein and 
mediate the interaction between DYRK1A and XPF, and DYRK1A phosphorylates 
XPF to stabilize ERCC1-XPF.  I used DYRK1A kinase activity inhibitor Harmine 
and analyzed its effects against ERCC1 and XPF levels (Figure 14).  Even though 
the marker of kinase inhibition, Cyclin D1 levels were elevated (Chen et al., 2013), 
cellular levels of ERCC1 and XPF were not strikingly changed. DYRK1A kinase 




2-3.   Discussion 
In this study, I identified DCAF7 (also known as WDR68 or HAN11) as a novel 
interacting protein of ERCC1-XPF by a proteomic approach.  Co-
immunoprecipitation experiments confirmed their interaction and suggested a direct 
association of DCAF7 with XPF but not ERCC1, leading us to speculate an indirect 
interaction with ERCC1 probably via XPF. 
Like most of WD40 proteins with seven WD40 repeats, DCAF7 forms a seven-
bladed -propeller structure, although it contains only five WD40 repeats (Miyata et 
al., 2014).  One of known functions of DCAF7 is to control the cellular signaling as 
a scaffold protein of multiprotein complex or an adaptor protein recruiting 
downstream proteins by facilitating protein-protein interactions.  DCAF7 binds to 
DYRK1A and DYRK1B belonging to the dual specificity tyrosine phosphorylation-
regulated protein kinase (DYRK) family (Skurat and Dietrich, 2004; Nissen et al., 
2006; Mazmanian et al., 2010; Miyata et al., 2011).  DCAF7 also binds to MEKK1 
and HIPK2, facilitating complex formation and signal transduction between the two 
protein kinases (Ritterhoff et al., 2010).  Conversely, DYRK1A appears to contribute 
to the nuclear localization of DCAF7 through the physical interaction, independent 
of its kinase activity (Miyata et al., 2011).  
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Another known function of DCAF7 is as a substrate receptor of Cul4-DDB1 E3 
ligase complex.  The Cul4-DDB1 complex is a member of Cullin-RING finger E3 
ligase family, which ubiquitinates target proteins (substrates) and mainly induces 
their proteasomal degradation.  A large number of substrate receptors, DCAFs, 
have been identified (Lee and Zhou, 2007) and play an important role in determining 
the substrate specificity of the complex.  DCAF7 was found to interact with DNA 
ligase I involved in DNA replication by joining Okazaki fragments, and to target it 
for ubiquitination by Cul4-DDB1 E3 ligase upon inhibition of cell proliferation (Peng 
et al., 2016). 
Here, I found that DCAF7 depletion reduced the steady state level of ERCC1-
XPF (Fig. 6) and hence the cellular NER activity (Fig. 13).  The mechanism how 
DCAF7 stabilizes ERCC1-XPF is currently unknown, but several possible models 
can be proposed.  First of all, the Cullin4-DDB1 complex is unlikely to participate 
in this mechanism, since knockdown of DDB1 influenced neither the basal level of 
ERCC1-XPF nor the downregulation of ERCC1-XPF upon DCAF7 depletion (Figs. 
12A and B).  On the other hand, Serine 256 of DCAF7 was recently reported to be a 
potential reactive site center of deubiquitination based on enhanced actively-based 
probes (ABPs) (Hewings et al., 2018).  It is possible to speculate that the potential 
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deubiquitinase activity of DCAF7 might protect ERCC1-XPF from proteasomal 
degradation.  However, it is currently unclear whether DCAF7 indeed possesses 
deubiquitinase activity. 
A more plausible model would be that DCAF7 may function as an adopter 
protein to stabilize ERCC1-XPF.  In fact, it was recently reported that DCAF7 is 
required for normal levels of DYRK1A and DYRK1B at a posttranslational level in a 
ubiquitin-proteasome-independent manner, although its detailed mechanism 
remains elusive (Yousefelahiyeh et al., 2018).  In the context of this model, the 
molecular chaperone TRiC (TCP1 ring complex), also known as CCT (chaperonin 
containing TCP1), is possibly involved in DCAF7-mediated ERCC1-XPF 
stabilization.  Nishida’s group reported that TRiC binds to DCAF7 and promotes its 
folding, DYRK1A binding and nuclear accumulation (Miyata et al., 2014).  Similarly, 
it has been also reported that TRiC binds to CSA, another DCAF protein with WD40 
repeats, ensures its proper folding and complex formation with Cul4-DDB1 (Pines et 
al., 2018).  It should be noted that, in our mass spectrometry analysis of ERCC1- or 
XPF-bound fraction, all of eight components of TRiC were detected (Table 2).  I also 
obtained the result that TCP1 knockdown causes the downregulation of ERCC1-XPF 
level, as seen in DCAF7 knockdown (Figs. 10D and E), suggesting the possible 
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implication of TRiC in the DCAF7-mediated stabilization of ERCC1-XPF.   
Another potential coplayer with DCAF7 may be protein kinase(s) that interacts 
with DCAF7.  DCAF7 was reported to recruit DYRK1A and HIPK2 to the 
adenovirus E1A protein and mediate their interaction for phosphorylation 
(Glenewinkel et al., 2016).  More recently, DCAF7 was found to stabilize and tether 
DYRK1A to RNA polymerase II, which promotes the hyperphosphorylation of its C-
terminal domain (CTD) by DYRK1A and hence transcription of myogenic genes (Yu 
et al., 2019).  In this model, some kinase(s) is possibly recruited to ERCC1-XPF 
complex or XPF before hetero-dimerization and facilitate the phosphorylation of XPF 
and/or ERCC1, thereby enhancing ERCC1-XPF stability.  I need to test the 
possibility that protein kinases such as DYRK1A/B, HIPK2 and MEKK1 are also 
involved in the DCAF7-mediated ERCC1-XPF stabilization in near future.   
In this study, I demonstrated that DCAF7, a novel interacting protein of 
ERCC1-XPF, plays some role in maintaining the cellular levels of ERCC1-XPF and 
nucleotide excision repair.  As already mentioned, DCAF7 also functions in the 
negative regulation of the cellular level of DNA ligase I in quiescent cells, collectively 
suggesting that DCAF7 is one of key players controlling DNA metabolism.  The 
cellular level of ERCC1-XPF is well known to influence the efficacy of platinum-
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based cancer chemotherapy.  This study provides a new insight into the regulatory 





Materials and Methods 
Cell lines and culture conditions 
Parental Flp-In™ T-REx™ 293 (Invitrogen) and its derivative cell lines conditionally 
expressing FLAG-ERCC1-6xHis or FLAG-XPF-6xHis upon tetracycline or 
doxycycline treatment were grown in Dulbecco’s modified Eagle medium (DMEM) 
(Gibco) supplemented with 10% fetal bovine serum (Sigma) and 10 g/ml Penicillin-
Streptomycin (Gibco).  U2OS, HeLa and HEK293T cells were grown in DMEM 
(Wako) with 10% fetal bovine serum (Sigma) and 50 g/ml Gentamicin (Nacalai 
tesque).  All cell lines were cultured at 37oC in a humidified 5% CO2 atmosphere. 
 
Silver stain 
The gel of SDS-PAGE is fixed by incubating with fix solution (50% MeOH, 12% Acetic 
Acid, 0.0185% HCHO) for one hour. The gel was washed with 50% ethanol for three 
times for 20 min each. The gel was pre-treated by incubating with pre-treat solution 
(0.02% sodium thiosulfate) for one minute, washed with water three times for 20 
seconds each. The gel was impregnated by incubating with impregnate solution 
(12mM silver nitrate, 0.02775% HCHO) for 20 min, and washed twice by water for 
20 seconds each. The gel was developed by incubated with develop solution (0.02% 
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sodium thiosulfate, 12% w/v NaCO3) until bands of proteins become visible level, 
washed with water. The reaction was stopped by incubating with distain solution 
(12% acetic acid, 60% methanol, 1.2% glycerol). 
 
Identification of ERCC1-XPF-interacting proteins by mass spectrometry  
Flp-InTM T-RExTM 293 cell line (control) and Flp-InTM T-RExTM 293/FLAG-ERCC1-
6xHis or FLAG-XPF-6xHis cell lines were incubated with 1 g/ml tetracycline for 48 
h to induce double-tagged bait proteins.  Cell lysates were prepared in the lysis 
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) 
containing EDTA-free protease inhibitor cocktail (Roche), supplemented with 
imidazole (final conc. 10 mM) (Sigma) and incubated with Ni-NTA agarose (Qiagen) 
for 1 h at 4oC.  After washing with the lysis buffer containing 10 mM imidazole, 
bound fractions were eluted with the lysis buffer containing 200 mM imidazole. The 
eluates were incubated with anti-FLAG antibody agarose (Sigma) for 12 h at 4oC.  
The proteins bound to agarose were washed three times and eluted by incubating 
with the lysis buffer containing 150 g/ml 3xFLAG peptide (Sigma) for 1 h at 4oC. 
The eluates were concentrated by chloroform-methanol extraction, dissolved in SDS 
sample buffer and fractionated by NuPAGE 10% Bis-Tris Protein Gels (Invitrogen).  
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The mass spectrometry analysis was conducted in the UNC Michael Hooker 
Proteomics Center. 
 
Construction of expression vectors 
A plasmid clone containing human DCAF7 cDNA was obtained from the Riken DNA 
bank (#HGX001752, Clone name: IRAK004G08).  DCAF7 cDNA was subcloned into 
the pEF6/Myc-His vector (Thermo Fisher Scientific) using PCR with the primers, 5'-
GTGGAATTCATGTCCCTGCACGGCAAACG (sense) and 5'-
CGAGCGGCCGCCCACTCTGAGTATCTCCAGGC (antisense), or the pEF6-2xFLAG 
vector (Kind gift from Dr. Yamashita) by PCR with the primes, 5'-
ATACATATGTCCCTGCACGGCAAACGGAA (sense) and 5'-
CGAGCGGCCGCCTACACTCTGAGTATCTCCA (antisense). MID1 was also 
obtained from Riken DNA bank (Catalog#: HGX046310, Clone #: IRAK115M22) and 
Myc-tagged by subcloned into pEF6-Myc-His B. cDNAs of STUB1 (912, 11052 E08); 
KCTD13 (990, 11032 F11); RNF2 (1011, 11033 C01); FBXO22 (1212, 31006 F02) were 
obtained from Lineberger Tissue Culture Facility, hORFeome V5.1. and were 
inserted into the empty vector, pcDNA3-3Myc-DEST, which was kindly provided by 
Dr. Yue Xiong and 3xMyc-tagged by Gateway™ LR Clonase™ Enzyme mix (Thermo 
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Fisher Scientific) according to the manufacturer’s instruction. TRIM25 (#12449), 
USP7 (#46751), USP11 (#22566), USP30 (#22578), USP46 (#22584) were obtained 
from Addgene. cDNAs of USP11, USP30, and USP46 are Myc-tagged by subcloned 
into pEF6-Myc-His B. GFP-RNF220 (pcDNA5-FRT/TO-GFP RNF220, DU Number: 
DU33230), GFP-CBL (pcDNA5-FRT/TO-GFP CBL, DU Number: DU31284) were 
obtained from MRC Protein Phosphorylation and Ubiquitylation Unit. 
 
Immunoprecipitation 
HEK 293T cells were transfected with various combinations of plasmids, pEF6/Myc-
His, pEF6/DCAF7-Myc-His, pEF6/XPF-Myc-His, pEF6-2xFLAG, pEF6-2xFLAG-
DCAF7, pEF6/3xFLAG-ERCC1, pcDNA3.1(+)/ERCC1 and pcDNA3.1(+)/XPF, and 
incubated for 48 h.  Cell lysates were prepared with the NP-40 lysis buffer (50 mM 
Tris-Cl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40) supplemented with EDTA-free 
protease inhibitor cocktail (Roche or Nacalai tesque), and incubated with anti-FLAG 
antibody resin (Wako) or anti-Myc antibody resin (Wako) for 1 h.  After washing 
with the NP-40 lysis buffer three times, bound proteins were eluted by boiling with 




Antibodies and siRNA 
The antibodies used in this study were as follows: anti-DCAF7 (EPR8712, Abcam), 
anti-ERCC1 (GTX129282, GeneTex), anti-TCP1 (sc-53454, Santa Cruz 
Biotechnology), anti-PSMD14 (A303-857A-T, Bethyl), anti-USP11 (A301-613A-T, 
Bethyl), anti-FLAG (PM020, MBL), anti-Myc (562, MBL).  I also used home-made 
monoclonal antibodies against XPF (clone 19-16) and DDB1 (clone 43233-3-1) 
(Cosmo bio). 
The siRNAs were obtained from Sigma-Aldrich: DCAF7 #1, 5’- 
GGAACAAGCAGGACCCUAAdTdT; DCAF7 #2, 5’-
GGUGUUAGGGCGAGUGAAUdTdT.  TCP1 #1, 5’-
GACCAAAUUAGACAGAGAdTdT; TCP1#2, 5’- 
GCAAGGAAGCAGUGCGUUAdTdT; PSMD14, 5’-
GGCAUUAAUUCAUGGACUAdTdT. USP11, 5’-
ACCGATTCTATTGGCCTAGTAdTdT. DDB1 siRNA was obtained from Cosmo Bio, 
5’-GAAUUCAAUAAGGGCCUUdTdT.  I also used siRNA Universal Negative 
Control #1 (Sigma) as control siRNA.  U2OS or HeLa cells were transfected with 
siRNA using LipofectamineTM RNAiMAX Transfection Reagent (Thermo Fisher 





Enzyme-linked immunosorbent assay (ELISA) 
Cells grown in 35-mm dish were irradiated with 10 J/m2 of UV-C from germicidal 
lamps (Toshiba, GL-10) and incubated for various periods.  Genomic DNAs were 
isolated with the Geno Plus Genomic DNA Extraction Miniprep system (Viogene), 
and the amount of 6-4PP was measured by using 64M-5 antibody as described 
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Table 1.  Proteomic analysis data on E3 ligases and deubiquitinases. 
The numbers of peptides from 14 kinds of E3 ligases and 5 kinds of deubiquitinases detected in mass 
spectrometry are listed.  Data on XPA, MSH2 and SLX4, well-known interactors of ERCC1-XPF was 










Table 2.  Proteomic analysis data on TRiC/CCT components 
All eight components of TRiC/CCT were detected in mass spectrometry and the numbers of peptides 

















Figure 1.  Structure and functions of ERCC1-XPF 
(A) Schematic representation of various domains and known interaction regions of XPF and ERCC1.  




















Figure. 3  Overexpression of ERCC1 or XPF in Flp-In TREx 293 cells and tandem affinity purification. 
(A) Parental Flp-In™ T-REx™ 293 and its derivative cell lines conditionally expressing FLAG-ERCC1-
6xHis or FLAG-XPF-6xHis were treated with or without 1 g/mL tetracycline for 48 h and lysed. Each 
cell lysate was analyzed by western blotting with the indicated antibodies. (B) Cell lysate from 
tetracycline-treated Flp-In T-REx 293 /FLAG-ERCC1-6xHis cells was incubated with Ni-NTA agarose 
and subsequently with anti-FLAG antibody resin. Bound proteins were eluted with 3xFLAG peptides 
five times and remaining proteins bound to the resin were eluted by boiling with SDS sample buffer. 
Aliquots of samples from each step were separated on SDS-PAGE and analyzed by western blotting 
with anti-FLAG antibody. (C) Cell lysates from the three cell lines were processed for tandem 
purification as described in (B), and the lysates (Input) and the precipitates (Pellet) were analyzed by 
western blotting with the indicated antibodies. (D) Each fraction of tandem purification steps was 
separated on SDS-PAGE and visualized by silver staining. 
 
  









Figure.4  Co-immunoprecipitation experiments after transient expression of various candidate 
interactors and ERCC1. 
An epitope-tagged version of various candidate interactors and FLAG-tagged or non-tagged ERCC1 
were transiently co-expressed in HEK293T cells for 48 h. Cell lysates were precipitated by anti-FLAG 








Figure. 5  Structures of DCAF7 and TRiC/CCT 






Figure. 6  DCAF7 depletion causes reduction of cellular levels of ERCC1 and XPF, while USP11 
depletion diminishes only ERCC1 level. 
U2OS cells were transfected with control siRNA, DCAF7 siRNA (#1) or USP11 siRNA and incubated 










Figure 7.  ERCC1-XPF binds to DCAF7 
 (A and B) DCAF7-Myc and/or FLAG-ERCC1 were ectopically expressed in HEK293T cells and cell 
lysates were immunoprecipitated by anti-FLAG antibody resin (A) or anti-Myc antibody resin (B).  (C 
and D) FLAG-DCAF7 and/or XPF-Myc were expressed in HEK293T cells and precipitated by either 
anti-Myc (C) or anti-FLAG antibody resin (D).  The precipitates were analyzed by western blotting 







Figure 8.  DCAF7 binds to XPF but not ERCC1  
(A and B) DCAF7-Myc and/or FLAG-ERCC1 were ectopically expressed in XP2YO(SV) cells and cell 
lysates were immunoprecipitated by anti-FLAG antibody resin (A) or anti-Myc antibody resin (B).  (C 
and D) FLAG-DCAF7 and/or Myc-tagged XPF (C) or non-tagged XPF (D) were expressed in XP2YO(SV) 
cells and precipitated by either anti-Myc (C) or anti-FLAG (D) antibody resin.  (E) The same amounts 
of Non-tagged ERCC1 and FLAG-DCAF7 expression plasmids (0.65 g each) were co-transfected with 
an increasing amount (0.65-5.2 g) of XPF-Myc expression plasmid into XP2YO(SV) cells.  The total 
amount of DNA was adjusted by empty vector pEF6/Myc-His.  After 48 h, cell lysates were prepared 
and immunoprecipitated by anti-FLAG antibody resin.  Each sample was analyzed by western blotting 










Figure 9.  DCAF7 interacts with both N-terminal or C-terminal half of XPF.  
(A) A schematic illustration of two kinds of XPF deletion mutants. (B and C) FLAG-DCAF7 and XPF(1-
515)-Myc or XPF(516-916)-Myc were ectopically expressed in XP2YO(SV) cells and cell lysates were 
immunoprecipitated by anti-FLAG antibody resin. The precipitates were analyzed by western blotting 










Figure 10.  Depletion of DCAF7 reduces the cellular levels of ERCC1-XPF.  
(A) U2OS cells were transfected with DCAF7 siRNA (#1) and incubated for the indicated period of time.  
After cell lysis, each sample was analyzed by western blotting with the indicated antibodies (left panel).  
An asterisk indicates non-specific bands.  The signal intensity of each band was quantified and 
adjusted using internal control -actin (right panel).  (B - E) U2OS cells were transfected with either 
control siRNA or DCAF7 siRNA (#1) (B) or TCP1siRNA (#1) (C).  After 72 h, cell lysates were 
prepared and analyzed by western blotting with the indicated antibodies.  The impacts of DCAF7 or 
TCP1 knockdown on ERCC1-XPF level were tested three times, and the mean and SD were shown in 




Figure 11.  Depletion of DCAF7 reduces the cellular levels of ERCC1-XPF. 
(A) HeLa cells were transfected with DCAF7 siRNA #1 or #2 as described in the “Materials and Methods” 
and incubated for 72 h.   Cell lysates were prepared and analyzed by western blotting with the 
antibodies specific for DCAF7, XPF or ERCC1.  -actin was used as internal control. (B) U2OS cells 
were transfected with TCP1 siRNA #1 or #2 (see the “Materials and Methods”) and lysed after 72-h 
incubation.   Cell lysates were analyzed by western blotting with the indicated antibodies. 
Figure 12.  DCAF7-mediated regulation of ERCC1-XPF level is independent of Cul4-DDB1 E3 ligase 
and 26S proteasome. 
(A and B) U2OS cells were transfected with DDB1 siRNA (A) or various combinations of control siRNA, 
DDB1 siRNA and DCAF7 siRNA (#1) (B) and incubated for 72 h.  (C) U2OS cells were transfected with 
DCAF7 siRNA (#1) and incubated for 12 h.  After addition of MG-132 (final 10 M) or DMSO, the cells 
were further incubated for 12 h.  (D) U2OS cells were transfected with control siRNA, PSMD14 siRNA 
or/and DCAF7 siRNA (#1) and incubated for 72 h.  Cell lysates were prepared and analyzed by western 
blotting with the indicated antibodies.  The relative band intensities adjusted using internal control 















Figure 13.  Depletion of DCAF7 suppresses the cellular activity of 6-4PP repair. 
(A) HeLa cells were transfected with DCAF7 siRNA (#1) and incubated for 72 h.  The cells were 
irradiated with 10 J/m2 of UV-C and further incubated for 1 or 2 h.  Genomic DNA was purified from 
each sample and analyzed for the repair kinetics of 6-4PP using ELISA.  Each point represents the 
mean of three experiments and bars indicate the SD (left panel).  Knockdown of DCAF7 and 
subsequent downregulation of ERCC1-XPF were also monitored by western blotting of cell lysates 
prepared from the same samples (right panel).  The relative band intensities adjusted using internal 
control β-actin were shown below each band.  (B) Flp-In T-REx 293/FLAG-XPF-6xHis cells were 
transfected with DCAF7 siRNA and incubated for 48 h.  Doxycycline was added to the cell culture at 
a final concentration of 1 g/ml and cells were further incubated for 24 h.  After irradiation with 10 
J/m2 of UV-C, the repair kinetics of 6-4PP (left panel) and the protein levels of DCAF7, XPF and ERCC1 


























Figure 14.  DYRK1A kinase inhibitor Harmine doesn’t significantly affect the cellular level of 
ERCC1-XPF 
U2OS cells were incubated with 10 mM or 20 mM Harmine, a DYRK1A kinase inhibitor, for 24 or 48 h. 
Cell lysates were prepared and analyzed by western blotting with the indicated antibodies. 
 
 
